BioMedomics' Unattributed - II Round

BioMedomics raised a round of funding on July 28, 2017.

BioMedomics is developing advanced highly sensitive and quantitative rapid point-of-care (POC) diagnostic platforms and novel disease specific diagnostic tests for the $16 billion POC diagnostic marke…

Articles about BioMedomics' Unattributed - II Round: